InNeuroCo has been acquired by Integer
The owners of InNeuroCo has sold the company to Integer (NYSE:ITGR).
Founded in 2014 and headquartered in Pembroke Pines, Florida, InNeuroCo is a leading founder-owned designer and contract manufacturer of ultra-precise, highly engineered neurovascular catheters. InNeuroCo’s primary products are single-use catheters principally used in interventional neurovascular procedures for the treatment of ischemic strokes and aneurysms. Offering turnkey product design and development, supported by comprehensive domestic manufacturing capabilities, InNeuroCo serves as a mission-critical supply partner to the world’s preeminent medical device OEMs.
With approximately US$1.4 billion in annual revenue, Integer is one of the largest medical devices outsource manufacturers in the world, serving the cardiac, vascular, rhythm management and neuromodulation markets.
Oaklins TM Capital in the US served as the exclusive financial advisor to InNeuroCo in its sale to Integer (NYSE:ITGR).



Marc Litzenberg
President and CEO, InNeuroCo
Sprechen Sie mit dem Deal Team
James McLaren
Oaklins TM Capital
Michael S. Goldman
Oaklins TM Capital
John Dean
Oaklins TM Capital
Bradley S. Goldstein
Oaklins TM Capital
Transaktionen
Cerbios-Pharma wurde von HAS Healthcare Advanced Synthesis übernommen.
Cerbios-Pharma S.A. wurde von HAS Healthcare Advanced Synthesis S.A. übernommen. Gemeinsam bilden sie eine weltweit führende CDMO-Gruppe mit komplementären Stärken in Entwicklung, Produktion und regulatorischer Unterstützung chemischer und biologischer Wirkstoffe. Die neue Gruppe vereint technologische Exzellenz mit umfassendem Know-how für die Anforderungen des globalen Pharmamarkts.
Mehr erfahrenPharma-Skan & Skan-Medic have been acquired by Brygge Partners
Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.
Mehr erfahrenThe Canton of Solothurn had a valuation report prepared for its hospitals
The Canton of Solothurn is the owner of Solothurner Spitäler AG (soH), with its three hospitals in Solothurn, Olten and Dornach.
Mehr erfahren